First Time Loading...

Invitae Corp
NYSE:NVTA

Watchlist Manager
Invitae Corp Logo
Invitae Corp
NYSE:NVTA
Watchlist
Price: 0.019 USD -35.59% Market Closed
Updated: Apr 18, 2024

ROE
Return on Equity

311.7%
Current
-128%
Average
3%
Industry
Positive for the last year
311.7%
Negative average
-128%
Better than average
Better than industry value

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
311.7%
=
Net Income
-1.4B
/
Equity
-560.1m

ROE Across Competitors

ROE Comparison
Invitae Corp Competitors

Country Company Market Cap ROE
US
Invitae Corp
NYSE:NVTA
5.4m USD
312%
US
Cigna Group
XMUN:CGN
96.1B EUR
11%
US
Cigna Corp
NYSE:CI
101.2B USD
11%
US
CVS Health Corp
NYSE:CVS
88.4B USD
11%
DE
Fresenius Medical Care AG
XMUN:FME
20.5B EUR
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.8B USD
5%
DE
Fresenius SE & Co KGaA
XETRA:FRE
14.9B EUR
-3%
US
Quest Diagnostics Inc
NYSE:DGX
14.1B USD
14%
US
DaVita Inc
NYSE:DVA
11.3B USD
78%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.4B EUR
4%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
Invitae Corp
NYSE:NVTA
Country US
Market Cap 5.4m USD
ROE
312%
C
Cigna Group
XMUN:CGN
Country US
Market Cap 96.1B EUR
ROE
11%
Cigna Corp
NYSE:CI
Country US
Market Cap 101.2B USD
ROE
11%
CVS Health Corp
NYSE:CVS
Country US
Market Cap 88.4B USD
ROE
11%
Fresenius Medical Care AG
XMUN:FME
Country DE
Market Cap 20.5B EUR
ROE
4%
Laboratory Corporation of America Holdings
NYSE:LH
Country US
Market Cap 16.8B USD
ROE
5%
F
Fresenius SE & Co KGaA
XETRA:FRE
Country DE
Market Cap 14.9B EUR
ROE
-3%
Quest Diagnostics Inc
NYSE:DGX
Country US
Market Cap 14.1B USD
ROE
14%
DaVita Inc
NYSE:DVA
Country US
Market Cap 11.3B USD
ROE
78%
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Country DE
Market Cap 10.4B EUR
ROE
4%
Oak Street Health Inc
NYSE:OSH
Country US
Market Cap 9.5B USD
ROE
464%

Profitability Report

View the profitability report to see the full profitability analysis for Invitae Corp.

Full Profitability Report

See Also

Summary
NVTA intrinsic value, competitors valuation, and company profile.
DCF Valuation
NVTA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NVTA stock valuation using valuation multiples.
Wall Street Estimates
NVTA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NVTA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
311.7%
=
Net Income
-1.4B
/
Equity
-560.1m
What is the ROE of Invitae Corp?

Based on Invitae Corp's most recent financial statements, the company has ROE of 311.7%.

ALPHA SPREAD
Join more than 128,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.